Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOral - PhysicianPharm

Phase I safety and bioimaging trial of ifabotuzumab in patients with glioblastoma

Hui Gan, Lawrence Cher, Po-Ling Inglis, Zarnie Lwin, Eddie Lau, Christian Wichmann, Uwe Ackermann, Alex McDonald, Ashray Gunjur, Nicole Coombs, Kirsten Remen, Nancy Guo, Sze-Ting Lee, Sylvia Gong, Jodie Palmer, Kunthi Pathmaraj, Graeme O'Keefe, Fiona Scott, Bryan Day, Andrew Boyd, Paul Thomas, Omar Ahmed, Dale Chappell, Cameron Durrant and Andrew Scott
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 104;
Hui Gan
1Olivia Newton-John Cancer Research Institute, Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence Cher
2Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Po-Ling Inglis
3Royal Brisbane and Womens Hospital Brisbane Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zarnie Lwin
3Royal Brisbane and Womens Hospital Brisbane Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eddie Lau
2Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Wichmann
1Olivia Newton-John Cancer Research Institute, Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uwe Ackermann
2Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex McDonald
1Olivia Newton-John Cancer Research Institute, Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashray Gunjur
2Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole Coombs
2Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirsten Remen
2Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nancy Guo
1Olivia Newton-John Cancer Research Institute, Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sze-Ting Lee
1Olivia Newton-John Cancer Research Institute, Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvia Gong
2Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jodie Palmer
1Olivia Newton-John Cancer Research Institute, Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kunthi Pathmaraj
2Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graeme O'Keefe
2Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fiona Scott
1Olivia Newton-John Cancer Research Institute, Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryan Day
4QIMR Berghofer Medical Research Institute Brisbane Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Boyd
1Olivia Newton-John Cancer Research Institute, Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Thomas
3Royal Brisbane and Womens Hospital Brisbane Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omar Ahmed
5Humanigen Inc Burlingame CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dale Chappell
5Humanigen Inc Burlingame CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cameron Durrant
5Humanigen Inc Burlingame CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Scott
1Olivia Newton-John Cancer Research Institute, Austin Hospital Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 62 no. supplement 1 104

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 18, 2021.

Copyright & Usage 
© 2021

Author Information

  1. Hui Gan1,
  2. Lawrence Cher2,
  3. Po-Ling Inglis3,
  4. Zarnie Lwin3,
  5. Eddie Lau2,
  6. Christian Wichmann1,
  7. Uwe Ackermann2,
  8. Alex McDonald1,
  9. Ashray Gunjur2,
  10. Nicole Coombs2,
  11. Kirsten Remen2,
  12. Nancy Guo1,
  13. Sze-Ting Lee1,
  14. Sylvia Gong2,
  15. Jodie Palmer1,
  16. Kunthi Pathmaraj2,
  17. Graeme O'Keefe2,
  18. Fiona Scott1,
  19. Bryan Day4,
  20. Andrew Boyd1,
  21. Paul Thomas3,
  22. Omar Ahmed5,
  23. Dale Chappell5,
  24. Cameron Durrant5 and
  25. Andrew Scott1
  1. 1Olivia Newton-John Cancer Research Institute, Austin Hospital Melbourne Australia
  2. 2Austin Hospital Melbourne Australia
  3. 3Royal Brisbane and Womens Hospital Brisbane Australia
  4. 4QIMR Berghofer Medical Research Institute Brisbane Australia
  5. 5Humanigen Inc Burlingame CA United States

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2021 to April 2025

AbstractFullPdf
May 20215300
Jun 20217700
Jul 20214200
Aug 20213000
Sep 20214800
Oct 20213000
Nov 20212200
Dec 20213800
Jan 20225300
Feb 20221600
Mar 20225100
Apr 202211900
May 20225000
Jun 20226400
Jul 20222900
Aug 20222700
Sep 20222400
Oct 20221100
Nov 20223900
Dec 20222200
Jan 20232700
Feb 20232200
Mar 20234100
Apr 20232000
May 20232700
Jun 20232400
Jul 20232800
Aug 20231400
Sep 20231700
Oct 20232200
Nov 20232600
Dec 20233900
Jan 20243900
Feb 20242700
Mar 20243600
Apr 20244900
May 20243200
Jun 20245000
Jul 20249800
Aug 202412400
Sep 20243400
Oct 20244600
Nov 20244100
Dec 20242900
Jan 20253600
Feb 20254200
Mar 20255400
Apr 20253400
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Phase I safety and bioimaging trial of ifabotuzumab in patients with glioblastoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Phase I safety and bioimaging trial of ifabotuzumab in patients with glioblastoma
Hui Gan, Lawrence Cher, Po-Ling Inglis, Zarnie Lwin, Eddie Lau, Christian Wichmann, Uwe Ackermann, Alex McDonald, Ashray Gunjur, Nicole Coombs, Kirsten Remen, Nancy Guo, Sze-Ting Lee, Sylvia Gong, Jodie Palmer, Kunthi Pathmaraj, Graeme O'Keefe, Fiona Scott, Bryan Day, Andrew Boyd, Paul Thomas, Omar Ahmed, Dale Chappell, Cameron Durrant, Andrew Scott
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 104;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Phase I safety and bioimaging trial of ifabotuzumab in patients with glioblastoma
Hui Gan, Lawrence Cher, Po-Ling Inglis, Zarnie Lwin, Eddie Lau, Christian Wichmann, Uwe Ackermann, Alex McDonald, Ashray Gunjur, Nicole Coombs, Kirsten Remen, Nancy Guo, Sze-Ting Lee, Sylvia Gong, Jodie Palmer, Kunthi Pathmaraj, Graeme O'Keefe, Fiona Scott, Bryan Day, Andrew Boyd, Paul Thomas, Omar Ahmed, Dale Chappell, Cameron Durrant, Andrew Scott
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 104;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses
  • Google Scholar

More in this TOC Section

Oral - PhysicianPharm

  • Evaluation of myocardial perfusion scintigraphy SPECT and CT images in patients with a history of COVID-19
  • Can absorbed radiation doses by organs and tumors after PRRT be estimated from a single SPECT/CT study?
  • Semiconducting polymers enhance Cerenkov radiation energy transfer for multimodal cancer theranostics
Show more Oral - PhysicianPharm

Advances in Clinical Neuroimaging

  • 18F-MK6240 longitudinal tau PET in ageing and Alzheimer's disease
  • Neuroinflammation in Semantic Variant Primary Progressive Aphasia
Show more Advances in Clinical Neuroimaging

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire